Pharmaceutical Regulatory Affairs Asia 2008 by cdc16374

VIEWS: 373 PAGES: 6

									                                                          Register & pay by 23rd May 2008 & SAVE up to SGD1095!
                                                            40% Discount for Government bodies, Hospitals & Academics




Pharmaceutical Regulatory Affairs Asia 2008
    Managing Regulatory Developments Efficiently with Practical Strategies
                       4–5 August 2008, Grand Copthorne Waterfront, Singapore


Featuring Key Regulatory and Industry Speakers:                        The first & only dedicated
                                                                       Pharmaceutical Regulatory Affairs
         Dr. Sonia R. Aqui, Chief, Product Services Division,
         Bureau of Food and Drugs, Philippines
                                                                       Summit in Asia!
         Mdm Saleha Md Ewan, Senior Pharmacist, Centre for              Critical issues to be discussed include:
         Product Registration, National Pharmaceutical Control          •   Recent Regulatory Developments in the Asian Region
         Bureau, Malaysia                                               •   Country Specific Market Updates including China and India
                                                                        •   ASEAN Harmonisation Efforts and Implementation
         Ms Lee Hui Keng, Head Policy & Planning, Health
                                                                        •   Strategies to Cope with Key Regulatory Issues:
         Products Regulation Group, Health Sciences Authority
         ( HSA ) , Singapore                                                – New Drug Applications ( NDAs )       – Clinical Trials in Asia
                                                                            – Product Registration in Asia         – Post-Market Surveillance
         Dr Lucky S. Slamet, Deputy for Therapeutic Product,                – Quality Assurance                    – Risk Management
         Narcotics, Psychotropic and Addictive Substance Control,           – Good Regulatory Practice ( GRP)      – Change Management
         The National Agency of Drug and Food Control
         ( NA – DFC ), The Republic of Indonesia                       Event Highlights:
         Mr. Andrew Notley, Associate Director Regulatory Affairs      • Excellent line-up of expert speakers from BOTH government
         Asia Pacific, Gilead Sciences, Australia                         REGULATORS & industry PRACTITIONERS
                                                                       • Seminar-style sessions for in-depth discussion and sharing
         Ms. Chadaporn ( Miang ) Tanakasemsub, Regional                  of practical strategies
         Regulatory Affairs Director, Asia Pacific, Bausch & Lomb       • 2 parallel tracks for selection
         ( HK ) Ltd., Hong Kong                                        • 10 mini-workshops to choose from
                                                                       • 2 separately bookable post-conference masterclasses
         Ms. Hiew Fee Ying, Director for Medical & Regulatory          • Longer networking hours
         Services in Asia-Pacific, UCB Pharma Asia-Pacific Sdn.
         Bhd., Malaysia
                                                                        PLUS 2 Post-Conference Masterclasses:
         Ms. Malo Garganera, Director Regulatory Affairs,               Wednesday 6 August 2008
         United Laboratories Inc., Philippines
                                                                        ( A ) Regulatory requirements for pharmaceutical product
         Dr. Kerwin Low, Director Regulatory Affairs, Asia Pacific,            registration in India
         GlaxoSmithKline Pte Ltd, Singapore                             ( B ) Certification according to ISO 15378:2006: Primary
                                                                              packaging materials for pharmaceutical products – Particular
         Dr. Alec Tiong, Senior Director and Regional Head Asian              requirements for the application of ISO 9001:2000 with
         Regulatory Affairs, Cross Pharma Global Regulatory Affairs,          reference to Good Manufacturing Practice ( GMP )
         Johnson & Johnson, Singapore


                                           www.ibc–asia.com/regulatory2008
Organised by:        Endorsed by:                                      Media Partners:




                                                  Bookings Hotline : +65 6514 3180                                      www.ibc-asia.com
            Pharmaceutical Regulatory Affairs Asia 2008
                    Managing Regulatory Developments Efficiently with Practical Strategies



                             4–5 August 2008, Grand Copthorne Waterfront, Singapore


Regulatory affairs professionals are the primary interpreters of the laws and regulations from the company’s R&D, manufacturing to
product marketing. It is their responsibility to be aware of the subtleties of regulations worldwide and to keep up-to-date on regulatory
changes. Developments in regulations directly affect strategies and decisions on product launching, and much time is usually spent
on tracking changes in regulations globally. At the senior level, regulatory affairs professionals need to further understand how the
regulatory process affects the bottom line and think strategically for the best benefits of the company. The stakes can be high: drug
approvals, as well as delays or failures, are prominent markers of success or failure in the pharmaceutical industry. Pharmaceutical
Regulatory Affairs Asia offers the best solutions for your regulatory needs within two days of intensive learning and networking!
Pharmaceutical Regulatory Affairs Asia is a must-attend for those keen to gain the knowledge of practical strategies to effectively cope
with regional regulations for pharmaceuticals. Explore the following key benefits for your attendance at this forum:
1.   LEARN about recent developments of regulatory requirements in key Asian markets
2.   DISCUSS strategies to efficiently cope with the evolving field of Regulatory Affairs
3.   DEVELOP guidelines on how to cross regulatory hurdles efficiently
4.   UNDERSTAND the regulatory environments in Asia
5.   NETWORK with key regulators and industry regulatory affairs leaders



Who SHOULD attend Pharmaceutical Regulatory Affairs Asia:
SECTORS                                                     DEPARTMENTS
• Pharmaceutical/Biopharmaceutical                          •   Regulatory Affairs & Strategy                      •   Quality Assurance & Control
  Companies                                                 •   Medical Affairs                                    •   Compliance & Licensing
• Clinical Research Organisations                           •   Scientific Affairs                                  •   Pharmaceuticals Manufacturing
• Regulatory Authorities                                    •   International Affairs                              •   Clinical Drug Development
• Health Ministries & Institutes                            •   Research & Development                             •   Dossier Management
• Regulatory Affairs Consultancies                          •   Drug Registration & Submission                     •   Sales & Marketing
• CROs/CMOs                                                 •   Drug Safety & Evaluation                           •   Corporate Management



Sponsorship & Exhibition Opportunities
• Are you keen to build a strong brand presence and recognition as a key provider in this space?
• Wish to announce your technology profile & capability to the key decision makers through a Technology Tutorial/Case Study?
• Generate business leads and showcase your company portfolio to decision makers
Various sponsorship & exhibition packages are available for your business needs.
For further discussions, please contact Ms Janice Tan, Tel: +65 6835 5126, Cell: +65 9366 4639, Email: janice.tan@ibcasia.com.sg


                                                   Day One – Monday 4 August 2008

08:00     Registration & Morning Coffee/Tea                                              09:40   Reviewing the Changing Pharmaceutical Regulatory Landscapes
09:00     Chairperson’s Opening Remarks                                                          in Key ASEAN Countries: MALAYSIA
                                                                                                 • Guidelines on the registration of pharmaceutical products
        THE EVOLVING REGULATORY FRAMEWORKS WITHIN ASEAN                                          • Requirements of licensing for importer, manufacturer and wholesaler
09:10     Reviewing the Changing Pharmaceutical Regulatory Landscapes                            • Surveillance of registered products in the market
          in Key ASEAN Countries: SINGAPORE                                                      • Post-market evaluation
                                                                                                 • Labelling requirements
          • Evaluation and approval of applications for new product license
          • Amendment and renewal of existing product license                                    Mdm Saleha Md Ewan, Senior Pharmacist, Centre for Product
                                                                                                 Registration, National Pharmaceutical Control Bureau, Malaysia
          • Review procedures of registered medicinal products
          • Evaluation, approval and monitoring of clinical trials for pharmaceuticals
          • Guidelines on drug registration and surveillance
          Ms Lee Hui Keng, Head Policy & Planning, Health Products Regulation
          Group, Health Sciences Authority, Singapore


          TO BOOK NOW: Call Bookings Hotline: +65 6514 3180 For more information visit: www.ibc–asia.com/regulatory2008
          Pharmaceutical Regulatory Affairs Asia 2008
                  Managing Regulatory Developments Efficiently with Practical Strategies

10:10   Reviewing the Changing Pharmaceutical Regulatory Landscapes                    12:45   Networking Luncheon
        in Key ASEAN Countries: PHILIPPINES
        • Adoption of the ACTD and ACTR on the pharmaceutical product                            REMOULDING THE REGULATORY FRAMEWORK IN ASIA
          registration for human use
        • Updates on guidelines for the processing of pharmaceutical                   14:00   MINI-WORKSHOP I: Developments & Updates on the Pharmaceutical
          product registration                                                                 Regulatory Requirements in India
        • Quality requirements for product processing, packaging and labelling                 India’s Pharma market is booming. It can produce cost effective, quality
        • Guidelines on new drug applications                                                  medicines. The changed legislative policies and amendments made in
        • Guidelines and procedure for the issuance of the principal certificate                Intellectual property rights have made India an attractive destination for
          of product registration                                                              the global Pharma industry. This presentation will provide an overview
                                                                                               of the latest developments of the regulatory requirements for the
        Dr Sonia R. Aqui, Chief, Product Services Division, Bureau of Food
                                                                                               product registration in India.
        and Drugs, Philippines
                                                                                               In addition, India has become a destination for clinical trial because
10:40   Morning Refreshment & Networking Session                                               of cost saving, potential for speedy recruitment of patients, the genetic
11:15   Reviewing the Changing Pharmaceutical Regulatory Landscapes                            diversity of Indian population is an added advantage. Hence data
        in Key ASEAN Countries: INDONESIA                                                      requirements for CTA in India will be discussed. An overview will be
                                                                                               provided on the Drugs and Cosmetic Act and Rules in addition to
        • Guidelines on obtaining import licenses for foreign pharmaceuticals                  the current regulatory requirements.
        • Requirements for the evaluation of product safety, quality and efficacy
                                                                                               Ms Garima Jain, General Manager Regulatory Affairs, Pharmalink
        • Understanding the drug application procedure                                         Regulatory Affairs Consulting Pvt. Ltd., India
        • Obtaining drug approvals: Marketing authorisation license
        Dr Lucky S. Slamet, Deputy for Therapeutic Product, Narcotics,                 15:00   Afternoon Refreshment & Networking Session
        Psychotropic and Addictive Substance Control, The National Agency of
        Drug and Food Control ( NA – DFC ) , The Republic of Indonesia.                15:30   MINI-WORKSHOP II: Developments & Updates on the Pharmaceutical
                                                                                               Regulatory Systems in China, Hong Kong, and Taiwan
11:45   PANEL DISCUSSION: ASEAN Pharmaceutical Regulatory
        Harmonisation: Challenges & Preparations on the Eve of                                 Although China, Hong Kong, and Taiwan are close in proximity and
        Implementation & Devising Strategies to Cope with the                                  are all Chinese-speaking countries, the regulatory environments in these
        Future Regulatory Trends                                                               three regions vary widely from one another. This session will provide an
        • Understanding the origin and current status of harmonisation                         overview of the regulatory systems for pharmaceutical products in China,
        • Forecasting the benefits and impact of mandatory implementation                       Hong Kong, and Taiwan, from clinical trial phase to product registration
          of ASEAN Common Technical Document (ACTD)                                            phase. Recent SFDA regulatory reforms and implications on the industry
        • Identifying constraints and challenges within each country                           will also be discussed. Finally, recommendations from a CRO’s
        • Maintaining regulatory intelligence to maximise the efficiency                        perspective to pharmaceutical companies on how to fulfil the different
          of regulatory processes                                                              regulatory requirements and accelerate product lunched will be shared.
        • Understanding how ASEAN countries will proceed with the                              Ms Karen Chu, Executive Director, Paraxel Apex International
          implementation of ASEAN harmonisation                                                Co., Ltd., Taiwan
        • Reviewing critical strategies for successful handling of evolving            17:00   Chairperson’s Closing Remarks
          regulatory framework
                                                                                       17:05   End of Day One followed by Networking Cocktail
        MODERATOR:
        Ms Bernadette Lopez, Regional Regulatory Affairs Manager for Asia
        Pacific, SciGen Ltd., Singapore
        PANELISTS:
        Dr Sonia R. Aqui, Chief, Product Services Division, Bureau of Food and
        Drugs, Philippines
        Mdm Saleha Md Ewan, Senior Pharmacist, Centre for Product
        Registration, National Pharmaceutical Control Bureau, Malaysia
        Dr Lucky S.Slamet, Deputy for Therapeutic Product, Narcotics,
        Psychotropic and Addictive Substance Control, The National Agency
        of Drug and Food Control (NA – DFC), The Republic of Indonesia
        Ms Lee Hui Keng, Head Policy & Planning, Health Products Regulation
        Group, Health Sciences Authority, Singapore



                                                    Day Two – Tuesday 5 August 2008

08:30   Registration & Morning Coffee/Tea                                                      United States, European and Australian regulatory environments provides
09:00   Chairperson’s Opening Remarks                                                          a strong platform for expansion into Asia Pacific, but the unique pit-falls
                                                                                               in the region are a challenge to anyone without extensive local experience
        Mr Andrew Notley, Associate Director Regulatory Affairs Asia Pacific,                   or the regulatory resources of an affiliate office in each country to draw
        Gilead Sciences, Australia                                                             upon. In this session Andrew will offer an insight into Gilead’s recent
09:10   Global Case Study – Learnings from Early Stages of Regional                            regulatory experiences in moving into Asia with some practical advice
        Expansion by a Growing Pharmaceutical Company                                          for those new to the region.
        Gilead Sciences is a successful pharmaceutical manufacturer currently                  Mr Andrew Notley, Associate Director Regulatory Affairs Asia Pacific,
        ranked as the second highest biotech company in market capitalisation,                 Gilead Sciences, Australia
        as well as recently being awarded No. 2 position in this year’s BusinessWeek   10:15   Morning Refreshment & Networking Session
        50 in their ranking of the best-performing companies. Success in the



        TO BOOK NOW: Call Bookings Hotline: +65 6514 3180 For more information visit: www.ibc–asia.com/regulatory2008
          Pharmaceutical Regulatory Affairs Asia 2008
                  Managing Regulatory Developments Efficiently with Practical Strategies


                                   TRACK A                                                                                 TRACK B
10:45   WORKSHOP 1: Constraints and Challenges in the Process of Product                       WORKSHOP 2: Regulatory Overview for Clinical Trials in Asia
                          Registration in Asia                                                 This presentation will provide an overview of the regulatory requirements
        In countries where local registration trial or local bridging study is                 for conducting local registration trials and global clinical development
        required prior to marketing authorisation submission, timely and successful            trials in Asia. An update will be provided on the processes of application
        completion of local studies is critical to the overall regulatory timeline.            for clinical trial approvals for both local and global trials. The strategic
        Close collaboration between Regional Harmonisation Initiatives and ICH                 and regulatory benefits for conducting global trials will be elaborated,
        Global Cooperation Group could be promising in overcoming some of the                  in addition to practical considerations that should be understood when
        challenges particularly in technical requirements. Other measures such                 deciding on involving Asian sites for global trials. Where appropriate,
        as the effective use of Certificate of Pharmaceutical Products ( CPP) &                 anti-HIV compounds and oncology compounds will be used as specific
        more transparency in the review and approval process which could be                    therapeutic areas to illustrate the regulatory processes and strategies for
        considered by Health Authorities for reducing the time gap between                     clinical trials. Lastly, the recent Japanese PMDA/KIKO guidance on global
        approval in ICH countries and Asia will be discussed.                                  clinical trials will be discussed together with its strategic implications
        Ms Hiew Fee Ying, Director for Medical & Regulatory Services in Asia-                  for companies.
        Pacific, UCB Pharma Asia-Pacific Sdn. Bhd., Malaysia                                     Dr Alec Tiong, Senior Director and Regional Head Asian Regulatory Affairs,
                                                                                               Cross Pharma Global Regulatory Affairs, Johnson & Johnson, Singapore

11:45   WORKSHOP 3: Challenges in the Implementation of Good Regulatory                        WORKSHOP 4: Guidelines and Strategies for New Drug Applications ( NDAs)
                    Practices ( GRP )                                                          The science of drug development continues to evolve, driven by medical
        In the challenging pharmaceutical environment currently experienced by                 need and advances in science and technology. In tandem, the costs
        all stakeholders, a robust drug regulatory framework is a necessity. ICH               of drug development continue to rise. While the amount of money put
        guidelines have been an important step towards creating this framework.                into R&D continues to grow, the rate of new products discovery is in
        However, several stumbling blocks are still present between drug                       decline. The ICH continues to develop new guidelines to keep pace
        regulatory authorities and pharmaceutical companies. Good Regulatory                   with these developments, making efforts to optimise and streamline the
        Practice ( GRP) represents a good opportunity to bridge the gap between                regulatory process. What are the impacts of these developments in ICH
        both parties. An introduction to the concept of GRP and the current                    on Asia? With more than 20 economies, each with their own distinct
        understanding of GRP will be presented. In this presentation, the benefits              regulatory agencies at different levels of development and each with
        and challenges of implementing GRP will also be discussed.                             different interpretation and implementation of guidelines, the region will
        Mr Kwa Kheng Hoe, Medical Affairs Manager, Nycomed Regional                            continue to present interesting regulatory challenges for pharmaceutical
        Office Asia, Malaysia.                                                                  companies. This talk will discuss some recent guidelines and their
                                                                                               potential impact on the region.
                                                                                               Dr Kerwin Low, Director Regulatory Affairs, Asia Pacific,
                                                                                               GlaxoSmithKline Pte Ltd, Singapore.
12:45   Networking Luncheon
14:00   WORKSHOP 5: Guidelines for Ensuring Pharmaceutical Product Quality                     WORKSHOP 6: Change Management in Drug Regulatory Affairs
        Numerous guidelines were issued by different countries, organisations                  This paper will discuss the dynamics in regulatory practice from a regulatory
        and authorities to ensure the pharmaceutical products can meet the                     person’s perspective in the pharmaceutical industry. Discussion will cover the
        expected quality. The guidelines include the Certificate of Pharmaceutical              stages to be taken in product registration from planning, evaluation, application,
        Product ( CPP) ; mutual recognition agreement; Pharmaceutical Inspection               and post approval changes. Thus focusing on regulatory issues relating to
        Cooperation Scheme ( PICS ) ; WHO’s prequalification project; quality                   compliance, product evaluation, validation, meeting timeline, knowledge
        assurance agreement; product assessment report; ICH Q8, Q9, Q10                        management, and skill enhancement of regulatory affairs personnel in coping
        guides etc. History on the development of these guidelines and impact                  with the dynamics of a constantly changing environment. The contribution of a
        on product quality will be discussed.                                                  regulatory person in ensuring conformity of products to regulation is important
        Mr Shih Younan, Vice President Quality Management, Scinopharm                          in all stages of product development. It does not end after the manufacturing
        Taiwan Ltd.                                                                            of a finished pharmaceutical product but extends until it has been distributed
                                                                                               to the end users to ensure a safe, quality and efficacious drug product.
                                                                                               Ms Malo Garganera, Director Regulatory Affairs, United Laboratories
                                                                                               Inc., Philippines
15:00   Afternoon Refreshment & Networking Session
15:30   WORKSHOP 7: Post-Market Surveillance & Risk Minimisation in Asia                       WORKSHOP 8: Regulatory Submission for Product Marketing
        The recently enacted FDA Amendments Act and stringent                                                  in Taiwan: Requirement and Strategies
        pharmacovigilance from most of the health authorities around the world                 • Local requirements in Taiwan
        gives them greater responsibility to ensure drug safety. Companies need                • Constraints and challenges for product submission
        to monitor their drug safety policies and procedures to ensure robust risk             • Requirements for biosimilars or follow-on biologics and generics
        management strategies, with the goal of transitioning these processes
                                                                                               • Regulations governing packaging, labelling and advertising
        to a more proactive approach. Asia Pacific is a growth engine for most
        global companies, therefore a good understanding of the drug safety                    • Patent protection for new products
        requirements in these markets will minimise the risks that might occur                 Ms Grace Fang, Director Medical & Regulatory Affairs, Takeda
        after product launch. However, the industry is still new to formulating risk           Chemical Industries (Taiwan) Co Ltd.
        minimisation strategies, and the increased post-market surveillance ( PMS )
        requirements will definitely be a challenge. This presentation will share
        B&L’s experience and discuss our perspective on a successful (global)
        PMS strategy and how we execute risk minimisation at a global level.
        Ms Chadaporn (Miang) Tanakasemsub, Regional Regulatory Affairs
        Director, Asia Pacific, Bausch & Lomb (HK) Ltd.
16:30   Chairperson’s Closing Remarks                                                  16:35   End of Conference


        TO BOOK NOW: Call Bookings Hotline: +65 6514 3180 For more information visit: www.ibc–asia.com/regulatory2008
          Pharmaceutical Regulatory Affairs Asia 2008
                  Managing Regulatory Developments Efficiently with Practical Strategies


        POST-CONFERENCE MASTERCLASSES – Wednesday 6 August 2008, 9am–5pm

MASTERCLASS A:                                                              MASTERCLASS B:
Regulatory Requirements for Pharmaceutical Product                          Certification According to ISO 15378:2006: Primary
Registration in India                                                       Packaging Materials for Pharmaceutical Products – Particular
                                                                            Requirements for the Application of ISO 9001:2000 with
COURSE DESCRIPTION
                                                                            Reference to Good Manufacturing Practice ( GMP)
India is emerging as a key player in pharmaceutical products including
medical devices on a global platform. This masterclass aims to              COURSE DESCRIPTION
serve as a forum to address the regulatory requirements to products         The primary packaging standard ISO 15378:2006 has been
registration in India. Besides discussing the product registration,         developed specifically for manufacturers of packaging material for
re-registration in India and how we should move forward to ensure           pharmaceutical products. The basis is the internationally recognised
efficient, accurate and auditable data submission to Indian regulatory       norm ISO 9001:2000. Secure a clear competitive advantage as
authorities. We will also look at the current regulatory environment for    a manufacturer through concrete requirements specific to your
Clinical trial applications and Medical devices registration in India.      industrial sector.
COURSE AGENDA                                                               COURSE AGENDA
Information about Drug Regulatory Requirements in India:                    The norms define requirements for Quality Management Systems for:
   • Organisation and function of CDSCO – Central Drugs Standard              • Design and development
     Control Organisation                                                     • Production
   • Laws for Drugs and Cosmetics                                             • Customer service and assembly
   • Drugs & Cosmetic Act 1940 and Rules 1945 along with                    The primary packaging material for pharmaceutical products
     all amendments                                                         covers all Good Manufacturing Practice ( GMP ) guidelines, which
   • Drugs and Magic remedies (Objectionable Advertisements) Act            is usually applied in the production of primary packaging material.
   • Schedule Y – Requirements and guidance for permission to               Additional specific requirements to the primary packaging industry
     Import and/or manufacture new drugs for sale or to undertake           would be defined in the standards which include:
     clinical trials                                                           • Batch tracking
   • Schedule M – GMP requirements in India                                    • Controlled environmental conditions
   • Medical devices manufacture and registration in India                     • Validations
MASTERCLASS LEADER                                                             • Risk management
     Ms Garima Jain, General Manager Regulatory Affairs,                    MASTERCLASS LEADERS
     Pharmalink Regulatory Affairs Consulting Pvt. Ltd., India
                                                                                     Ms Jocelyn delos Reyes, General Manager, TÜV Rheinland
                                                                                     Singapore Pte Ltd.
                                                                                     Ms Manineth A. Pulido, System Certification Manager,
                                                                                     TÜV Rheinland Singapore Pte Ltd.


                             Look out for our co-located event during the week of Pharma Asia Series!
                   Enjoy 25% discount on the registration when you register for Pharmaceutical Sales & Marketing!


                             Pharmaceutical Sales & Marketing Asia
           Winning & Locking in Market Share with Innovative Localised Knowledge and Strategies
                                                 6th & 7th August 2008, Singapore
6 TOP EVENT HIGHLIGHTS:
    1) Gain invaluable insights from over 20 international and regional practitioners who are excelling in the pharmaceuticals industry
    2) Equip yourselves with practical sales force effectiveness strategies for your market
    3) Identify the unique issues directly impacting pharmaceutical marketing & sales efforts in different Asian markets
    4) Assess the threat of generics and take pre-emptive moves to guard your market share
    5) Significantly increase your team’s ROI with innovative use of ethical marketing and sales strategies to access the physicians network
    6) Exclusive one-day sales force effectiveness symposium to ensure practical applications for your business success
FOR MORE INFORMATION, PLEASE VISIT THE DEDICATED EVENT WEBSITE TODAY www.ibc-asia.com/psm


        TO BOOK NOW: Call Bookings Hotline: +65 6514 3180 For more information visit: www.ibc–asia.com/regulatory2008
     If undelivered, please return to:
                                                                                                       PRINTED MATTER
                                                                                                       AIR MAIL
    No.1 Grange Road,
    #08-02 Orchard Building, Singapore 239693
    Tel: (65) 6732 1970 Fax: (65) 6733 5087 / (65) 6736 4312


                         Pharmaceutical Regulatory Affairs Asia 2008
                                                                                                                                                                                                                                                             HOTEL INFORMATION
                                                                                                                                                                                                                                                           Grand Copthorne Waterfront Hotel
                                                                                                                                                                                                                                                           392 Havelock Road,
                                                                                                                                                                                                                                                           Singapore 238865
                                                                                                                                                                                                                                                           Tel: (65) 6733 0880
                                                                                                                                                                                                                                                           Fax: (65) 6233 1034
                                                                                                                                                                                                                                                           Contact Person: Ivy Yeo
                                                                                                                                                                                                                                                           Email:
                                                                                                                                                                                                                                                           ivy.yeo@grandcopthorne.com.sg
                                                                                                                                                                                                                                                             5 EASY WAYS TO REGISTER
                                                                                                                                                                                                                                                           ✉        Mail the attached registration
                                                                                                                                                                                                                                                                    form with your cheque to
                                                                                                                                                        GROUP BONUS:                                                                                                IBC Asia (S) Pte Ltd,
                                                                                                                                                 Register 3 delegates and the 4th                                                                                   No. 1 Grange Road, #08-02,
                                                                                                                                                  delegate can attend for FREE                                                                                      Orchard Building,
                                                                                                                                                  (Only one discount scheme is applicable)                                                                          Singapore 239693.

                                       This label contains your priority booking code.                                                                                                                                                                     ☎        Customer Service Hotline:
                                                                                                                                                                                                                                                                          (65) 6514 3180
                                    To expedite registration, please do not remove label.
                                                                                                                                                                                                                                                                    FAX: (65) 6733 5087
If you have already received a copy of this brochure, we apologise. For reasons of confidentiality, your full particulars were not available to IBC Asia (S) Pte Ltd for dedupulication prior to mail drop.
                                                                                                                                                                                                                                                                          (65) 6736 4312
                                                              RESERVE YOUR PLACE TODAY!                                                                                                                                                                    E-MAIL:
                                                                                                                                                                                                                                                           register@ibcasia.com.sg
        Yes! I/We will attend the PHARMACEUTICAL REGULATORY AFFAIRS ASIA 2008 • 4–5 August 2008, Singapore
                                                                                                                                                                                                                                                           WEB:
  Ist delegate                                                                                           2nd delegate                                                                                                                                      www.ibc-asia.com/regyform.htm
  Name: Dr/Mr/Ms                                                                                         Name: Dr/Mr/Ms
                                                                                                                                                                                                                                                             PAYMENT
  E-Mail                                                                                                 E-Mail
                                                                                                                                                                                                                                                           All payments should be made in US or
  Job Title                                                                                              Job Title                                                                                                                                         Singapore dollars
  Mobile no                                                                                              Mobile no                                                                                             Please photocopy for additional delegates   • Payments by US$ / S$ bank draft or
                                                                                                                                                                                                                                                              cheque should be made in favour of
  Department                                                                                             Department                                                                                                                                          “IBC Asia (S) Pte Ltd” payable in
                                                                                                                                                                                                                                                              Singapore.
  Company                                                                                                                                                                                                                                                  • Payment by telegraphic transfer in
  Address                                                                                                                                                                                                                                                     US$ or S$ must be made to:
                                                                                                                                                                                                                                                              IBC Asia (S) Pte Ltd
  Post Code                                                                                              Country                                                                                                                                              A/CNo.: 260-457866-178 (USD)
  Tel                                                                                                    Fax                                                                                                                                                  A/CNo.: 147-059513-001 (SGD)
                                                                                                                                                                                                                                                              The Hongkong and Shanghai
  Name & Title of Approving Manager                                                                      E-Mail                                                                                                                                               Banking Corporation Limited
                                                                                                                                                                                                                                                              21 Collyer Quay, HSBC Building,
  Name & Title of Training Manager                                                                       E-Mail                                                                                                                                               Singapore 049320
  Main Business/Activity
                                                                                                                                                                                                                                                           IMPORTANT NOTE:
  Please tick              I enclose my Cheque/Draft payable to IBC Asia (S) Pte Ltd                                                                                                                                                                       Please quote the name of the delegate
                           I am paying by bank transfer (copy attached)                                                                                                                                                                                    and event title on the advice when
                           Payment by Credit Card:                               Amex                                    Visa            Mastercard                                                                                                        remitting payment. Bank charges are to be
                                                                                                                                                                                                                                                           deducted from participating organisations
  Card Holder:                                                                                                                            Signature:                                                                                                       own accounts. Attendance will only be
  Card Number:                                                                                                                            Expiry Date:                                                                                                     permitted upon receipt of full payment.
                                                                                                                                              (Please provide photocopy of front & back of your Credit Card)                                               Participants wishing to register at the door
    I cannot attend this event but                     I would like to purchase the conference documentation @ S$900/S$963 (with 7% GST)                                                                                                                   are responsible to ensure all details are as
  46050 WEB                                            Please put me on your mailing list.                                                                                                                                                                 published. IBC Asia will not be responsible
                                                                                                                                                                                                                                                           for any event re-scheduled or cancelled.
                                                                                                                                                                                                                                                           Please note that programme and speakers
                                                                                                   EARLY BIRD                              SPECIAL RATE                                NORMAL RATE                                                         are subject to change without notice.
   REGISTER TODAY
                                                                                     Register & pay before 23 May 2008          Register & pay before 20 June 2008          Register & pay after 20 June 2008
                                                                                                                                                                                                                                                           DATA PROTECTION
  Options                                                                                  Price                Saving                Price                Saving                  Price               Saving                                              The personal information entered during your
  ❑ 3 Day Package – 2 Day Conference + 1 Day Workshop                                   SGD $2795             SGD $1095            SGD $2995              SGD $895             SGD $3095              SGD $795                                             registration/order, or provided by you, will
                                                                                                                                                                                                                                                           be held on a database and may be shared
  ❑ 2 Day Package – 2 Day Conference only                                               SGD $2095             SGD $300             SGD $2295              SGD $100             SGD $2395
                                                                                                                                                                                                                                                           with companies in the Informa Group in
  ❑ 1 Day Package – 1 Day Workshop Only                                                 SGD $1395             SGD $100             SGD $1395              SGD $100             SGD $1495                                                                   the UK and internationally. Sometimes your
  ❑ Both Conferences – Pharmaceutical Regulatory Affairs Asia                                                                                                                                                                                              details may be obtained from or shared with
    plus Pharmaceutical Sales & Marketing Asia                                          SGD $3995             SGD $995             SGD $4195              SGD $795             SGD $4395              SGD $595                                             external companies for marketing purposes.
    Enjoy more than a 25% discount if you register for both conferences now!                                                                                                                                                                               If you do not wish your details to be used for
  A 7% Goods & Services Tax (GST) is applicable to all Singapore based companies for Singapore venue.                                                                                                                                                      this purpose, please contact the Database
  Fee includes luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.                                                                                                                        Manager Catherine Shen on catherine.
                               If you are unable to attend, a substitute delegate will be very welcome in your place. If this is not suitable, a 10% service charge will be payable.                                                                       shen@ibcasia.com.sg, Ph: +65 6835 5141 or
    CANCELLATIONS
    SUBSTITUTION               Registrations cancelled less than seven days before the event must be paid in full.                                                                                                                                         Fax: +65 6734 4053.


                                             REGISTER NOW! FAX BACK TO ( 65 ) 6733 5087 / ( 65 ) 6736 4312

								
To top